70 results
Page 3 of 4
SC TO-C
EX-99.2
ougrvxtpiise
2 Jun 21
Information about tender offer
5:20pm
6-K
EX-99.1
mjksn8 9qy3ddxnvu
2 Jun 21
Current report (foreign)
12:06pm
6-K
EX-99.2
i03gdhzeq6yq3uku6cz
2 Jun 21
Current report (foreign)
12:06pm
6-K
EX-99.1
wd46bg8p
23 Mar 21
Current report (foreign)
3:53pm
6-K
EX-99.1
lp6nlbr7o uqak
22 Mar 21
Current report (foreign)
12:42pm
6-K
EX-99.2
m1yh0
12 Nov 20
MorphoSys Reports Nine Months and Third Quarter
4:48pm
6-K
EX-99.1
s17rth8 yto
30 Sep 20
Current report (foreign)
11:00am
6-K
EX-99.1
8tu d24h7fhfzwjwa6xk
27 Mar 20
Current report (foreign)
3:29pm
6-K
EX-99.1
rkme 5cs803cm70
20 Mar 20
Current report (foreign)
2:15pm
6-K
EX-99.1
y0gr85cysgf0mz2oanyd
30 Oct 19
Third Quarter Interim Statement
10:03am
6-K
EX-99.2
9ekd ao5mw0m9eu6tjy
9 Aug 19
Current report (foreign)
6:18am
6-K
EX-99.1
or52o95r 1ay2e8
8 Aug 19
Half-Year Report January – June 2019
6:38am
6-K
EX-99.1
rl1v9p6a1fn
25 Jun 19
MorphoSys Presents Primary Analysis Data fromL-MIND Study of Tafasitamab (MOR208) in combination with Lenalidomide in r/r DLBCL at ICML 2019
6:13am
6-K
EX-99.1
ffvu2t55d
21 Mar 19
Current report (foreign)
6:14am